The Hippo effector TAZ cooperates with oncogenic β-catenin in experimental and human hepatoblastoma development
Junyan Tao(University of Pittsburgh), Antonio Cigliano(University of Sassari)
Cited by 0
Related Papers
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis
|Oncotarget|2017|38
Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma
|Medicina|2019|13
Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27KIP1 Regulation
|Medicina|2024|7
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma
|Journal of Experimental & Clinical Cancer Research|2024|6